Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: An observational study

The Lancet Infectious Diseases

Volumn 14, Issue 4, 2014, Pages 301-307

  Okike, Ifeanichukwu O ^a,b   Ribeiro, Sonia ^b   Ramsay, Mary E ^b   Heath, Paul T ^a   Sharland, Mike ^a   Ladhani, Shamez N ^a,b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; BLOOD CULTURE; CHILD; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; ENTEROBACTER; ENTEROCOCCUS; EPIDEMIC MENINGITIS; ESCHERICHIA COLI; FEMALE; FUNGAL MENINGITIS; HAEMOPHILUS INFLUENZAE; HUMAN; INCIDENCE; INFANT; LISTERIA MONOCYTOGENES; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEISSERIA MENINGITIDIS; NONHUMAN; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS; SALMONELLA; SCHOOL CHILD; SERRATIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; ENGLAND; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MENINGITIS, BACTERIAL; MENINGITIS, FUNGAL; MENINGITIS, MENINGOCOCCAL; MIDDLE AGED; MYCOBACTERIUM INFECTIONS; PNEUMOCOCCAL INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; WALES; YOUNG ADULT;

EID: 84896492685     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70332-3     Document Type: Article

References (21)

1. Ladhani SN Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom. Clin Ther 2012, 34:385-399.
2. Campbell H, Borrow R, Salisbury D, Miller E Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine 2009, 27(suppl 2):B20-B29.
3. Miller E, Andrews NJ, Waight PA, Slack MP, George RC Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011, 11:760-768.
4. Miller E, Andrews NJ, Waight PA, Slack MP, George RC Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine 2011, 29:9127-9131.
5. Reporting to the HPA: a guide for diagnostic laboratories HPA, (accessed Dec 1, 2013). http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Surveillance/SourcesOfSurveillanceData/survLaboratoryReporting/.
6. Ladhani SN, Flood JS, Ramsay ME, et al. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine 2012, 30:3710-3716.
7. Halperin SA, Bettinger JA, Greenwood B, et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine 2012, 30(suppl 2):B26-B36.
8. Findlow J Meningococcal group B vaccines. Hum Vaccin Immunother 2013, 9:1387-1388.
9. Prevention of early onset neonatal group B streptococcal disease: guideline no 36 2003, RCOG, Royal College of Obstetricians and Gynaecologists, London.
10. Verani JR, McGee L, Schrag SJ Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010, 59:1-36.
11. Lamagni TL, Keshishian C, Efstratiou A, et al. Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010. Clin Infect Dis 2013, 57:682-688.
12. Collins S, Ramsay M, Campbell H, Slack MP, Ladhani SN Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination?. Clin Infect Dis 2013, 57:1715-1721.
13. Mandatory Surveillance of Staphylococcus aureus bacteraemia PHE, (accessed Dec 1, 2013). http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/StaphylococcusAureus/EpidemiologicalData/MandatorySurveillance.
14. Mandatory surveillance of Escherichia coli bacteraemia PHE, (accessed Dec 1, 2013). http://www.hpa.org.uk/web/HPAweb&Page&HPAwebAutoListName/Page/1296687731211.
15. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011, 364:2016-2025.
16. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004, 351:1849-1859.
17. Voluntary reporting of of Staphylococcus aureus bacteraemia in England, Wales and Northern Ireland, 2010 HPA, (accessed Dec 24, 2013). http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1313155060238.
18. Michael B, Menezes BF, Cunniffe J, et al. Effect of delayed lumbar punctures on the diagnosis of acute bacterial meningitis in adults. Emerg Med J 2010, 27:433-438.
19. Riordan FA, Cant AJ When to do a lumbar puncture. Arch Dis Child 2002, 87:235-237.
20. Feverish illness in children: assessment and initial management in children younger than 5 years NICE, (accessed Dec 1, 2013). http://www.nice.org.uk/nicemedia/pdf/CG47QuickRefGuide.pdf.
21. Huang WC, Lee CH, Liu JW Clinical characteristics and risk factors for mortality in patients with meningitis caused by Staphylococcus aureus and vancomycin minimal inhibitory concentrations against these isolates. J Microbiol Immunol Infect 2010, 43:470-477.